Oracle completes $10 billion common stock and $10 billion notes offerings
No actual results or guidance were disclosed, so there is no beat, miss or in-line comparison to prior guidance; Oracle instead completed a $10 billion common-stock offering and a $10 billion five-tranche notes offering on November 4, 2026.
Key takeaways
1. The financing combined a closed $10 billion common-stock offering with a completed $10 billion five-tranche notes offering on November 4, 2026.
2. The underwriters purchased 86,206,897 common shares at $114.5906 per share; the filing does not disclose the price to the public or aggregate net proceeds.
3. The notes range from 7.000% due 2029 to 8.650% due 2046, with intermediate tranches due in 2031, 2033 and 2037.
4. Each note series has make-whole call provisions using the Treasury Rate plus 40 to 50 basis points before its respective par call date, followed by redemption at 100% of principal.
5. BofA Securities acted as representative of the several underwriters, while BNY Mellon Trust Company served as trustee, registrar, transfer agent, authenticating agent and paying agent for the notes.
6. The combined net proceeds may fund capital expenditures, debt repayment, future investments or acquisitions, cash dividends or common-stock repurchases.
7. The financing filing contains no earnings results or guidance.
Key metrics
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow ORCL in real time
Get material earnings, filing, IR, and earnings-call alerts by email.